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Aim: To examine the impact of beam rate on dose distribution in IMRT  plans and then to
evaluate agreement of calculated and measured dose distributions for various beam rate
values.
Background: Accelerators used in radiotherapy utilize some beam rate modes which can
shorten irradiation time and thus reduce ability of patient movement during a treatment
session. This aspect should be considered in high conformal dynamic techniques.
Materials and methods: Dose calculation was done for two different beam rates (100 MU/min
and  600 MU/min) in an IMRT plan. For both, a comparison of Radiation Planning Index (RPI)
and MU was conducted. Secondly, the comparison of optimal ﬂuence maps and correspond-
ing actual ﬂuence maps was done. Next, actual ﬂuence maps were measured and compared
with the calculated ones. Gamma index was used for that assessment. Additionally, posi-
tions of each leaf of the MLC were controlled by home made software.
Results: Dose distribution obtained for lower beam rates was slightly better than for higher
beam  rates in terms of target coverage and risk structure protection. Lower numbers of
MUs were achieved in 100 MU/min plans than in 600 MU/min plans. Actual ﬂuence maps
converted from optimal ones demonstrated more similarity in 100 MU/min plans. Better
conformity of the measured maps to the calculated ones was obtained when a lower beam
rate was applied. However, these differences were small. No correlation was found between
quality of ﬂuence map conversion and leaf motion accuracy.Conclusion: Execution of dynamic techniques is dependent on beam rate. However, these
differences are minor. Analysis shows a slight superiority of a lower beam rate. It does not
signiﬁcantly affect treatment accuracy.
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1.  Background
Medical accelerators (Clinacs – Varian Medical Systems, Palo
Alto, CA, USA) used at Radiotherapy Department, Center of
Oncology – Institute in Gliwice enable the use of a sliding
window IMRT  delivery method.1,2 These accelerators utilize
several beam rates, which correlate with dose rates. In this
investigation we  distinguish two terms: dose rate and beam
rate. Dose rate measurements are carried out in precisely
deﬁned conditions (depth in water, source-phantom surface
distance, ﬁeld size), according to international recommenda-
tions and reports. If dose rate measured in standard conditions
equals 1 Gy/min and measurement is made for 100 MU/min
beam rate (MUs, monitor units), then during 1 min  the dose
of 1 Gy is delivered. There are following beam rates available
for Varian accelerators: 100, 200, 300, 400, 500, 600 MU/min,
ranging from 1 up to 6 Gy/min. Nowadays, the beam rate of
300 MU/min is routinely applied.2
Selection of different beam rates does not affect dose dis-
tribution in non-dynamic techniques. Field sizes in static
techniques are constant and beam rate changes do not cause
meaningful changes in dose distribution calculated in com-
puter treatment planning systems. The situation is disparate
in dynamic techniques where ﬁeld sizes are changed during
a treatment session. Dose distribution calculated in a treat-
ment planning system (TPS) and presented on CT scans are
not visibly different when using various beam rates. How-
ever, some ﬁne differences can be found on dose–volume
histograms (DVHs).1,3 In IMRT  technique ﬁeld size is a func-
tion of time, therefore, beam rate and dose distribution
dependence becomes more  complicated. In everyday radio-
therapy, dynamic techniques are more  and more  often used.4,5
Dynamic techniques are applied either as a self-contained or
supplement therapy.1 In dynamic techniques such as IMRT,
the number of MUs  is higher than in other conformal but
static techniques because treatment ﬁeld is the sum of smaller
component segments. Consequently, in dynamic techniques
treatment session time is longer.3 It is known that a longer
treatment time can cause patient repositioning or move-
ment during a therapeutic session.3 Therefore, treatment time
shortening seems to be a good approach to avoid undesired
patient movements. It can be achieved by beam rate increase.
However, there is not enough data in the literature concerning
the inﬂuence of beam rate on dose distribution and radiother-
apy accuracy.
2. Aim
The aim of the study was to evaluate beam rate inﬂuence
on dose distribution, calculated in treatment planning system
and its execution during treatment session for two beam rates:
100 MU/min and 600 MU/min.
3. Materials  and  methodsIn order to calculate IMRT  dose distribution, Eclipse-Helios
v. 8.6 (Varian Medical Systems, Palo Alto, CA, USA) TPS was
utilized. Dose calculations were made for 11 patients withdiotherapy 1 7 ( 2 0 1 2 ) 97–103
prostate cancer. All plans were calculated for two beam rates:
100 MU/min and 600 MU/min. Dose distributions were calcu-
lated with AAA v.8.6.14 algorithm,6 for the same X-20MV beam
arrangement and optimization parameters, closing optimiza-
tion and reaching a plateau after the same time. The only
difference between both plans was in beam rate.
It may be debatable whether to perform two  optimiza-
tion processes – the one for 100 MU/min and the other one
for 600 MU/min. The authors applied separate calculations for
different beam rates from the beginning of the planning pro-
cess, while preserving the number and arrangement of the
beams, dose–volume constraints and number of iterations.
This methodological approach differs from the other one that
uses one optimization with one set of ﬂuence maps and two
dose distribution calculations for different beam rates. Obtain-
ing the same results for all cases examined and described later
in this work, allows us to argue that the differences arise only
from the use of two different beam rates thus conﬁrming the
correctness of the methodology adopted.
For both beam rates the following properties were com-
pared:
- dose distribution with the help of Radiation Planning Index
(RPI) computed with a self-made software,7
- number of MUs  per treatment plan,
- optimal and actual ﬂuence maps calculated in TPS, on the
base of gamma index calculated in OmniPro-I’mRT software
(IBA, Uppsala, Sweden),
- actual ﬂuence maps calculated in TPS and measured with
the electronic portal imaging device (EPID) by the mean of
gamma indices calculated with the Eclipse Portal Dosimetry
application,
- precision of dose delivery by leaves position monitoring
done with a self-made software MLCtracker.
3.1.  Comparison  of  dose  distributions
Dose distribution differences presented in the form of iso-
doses are often unclear particularly when differences between
two plans are small. It is difﬁcult to indicate the best plan,
considering both dose to target and organs at risk. Very
helpful in such cases are all sorts of evaluation factors and
dose–volume histograms (DVHs) allowing to compare dose
distribution in selected volumes in a more  exact way.1,3
RPI is a plan evaluation coefﬁcient, which takes into
account a dose–volume graph calculated for selected struc-
tures. On this basis, integral doses of organs at risk and
tumor volumes are analyzed. It also enables to assign spe-
ciﬁc weights to structures and to diversify their importance.
DVHs calculated in TPS for selected structures are exported
and used for RPI calculation. The value of RPI is within
the 0–1 range. The value of 1 is reported by the software
for the ideal plan.7 In computation, the following structures
were taken into account as organs at risk: bladder, rectum,
and femoral heads. Tumor volumes and possibly seminal
vesicles with appropriate margins (GTV, CTV, PTV) were con-
sidered as target volumes. This analysis evaluates which of the
plans, 100 MU/min or 600 MU/min, is better as regards target
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overage and organs at risk protection at the same time. For
oth types of plans, the average RPI was calculated.
.2. Comparison  of  MUs
or both beam rates the number of beams and their arrange-
ent were kept. Calculations of dose distributions and
Us  were done with the same optimization criteria, i.e.
ose–volume objectives, priorities deﬁned for the structures
nd equal time of optimization represented by number of
terations.1–3
It is expected that in the course of optimization different
otal numbers of MUs  per plan can be obtained for different
eam rates.
.3. Comparison  between  optimal  and  actual  ﬂuence
aps
he congruity between the optimal and the actual ﬂuence
as assessed with gamma index using the OmniPro-I’mRT
oftware. Pairs of ﬂuence maps were exported from TPS. The
riteria of 3% of the maximum dose difference and 2 mm
ose-to-agreement (DTA) were used. Optimal ﬂuence map
as the reference one. When the criteria were fulﬁlled the
amma index was smaller than 1 and doses in the analyzed
oints agreed.8,9 This statement is true in the case of one
elected point. However, in practice, dose assessment at mul-
iple points of a ﬂuence map  is necessary. Such evaluation is
sually done in several ways. Let us consider the two quanti-
ies: the average gamma index and the percentage or number
f points for which the criteria are met. The second quan-
ity describes well the compatibility of maps but does not
rovide information on the location of non-compliance. The
rst tool is not a perfect one, either. If the average gamma
s less than one, full compatibility of the maps is actually
xcluded. There are certainly points of dose non-compliance.
t should be noted that the average gamma value lower than
ne is possible even with some points not meeting the crite-
ia. Although, it can be concluded that a lower average gamma
alue indicates a better match of maps than the higher value.
n this paper, an average gamma value was chosen to analyze
he ﬂuence maps and further on the term gamma index will
e used to mean the average gamma index.
Optimal ﬂuence maps are ideal ﬂuence maps estimated
nitially by the iteration process in TPS. They meet the opti-
al  dose–volume objectives contained in the inverse planning
lgorithm. Optimal ﬂuence map  is then converted into an
ctual ﬂuence map  by a Leaf Motion Calculator (LMC). Actual
uence maps take into account leaf motion speed limits and
reatment delivery method. These maps are realized ﬁnally on
ccelerators.1,2
This part of the study attempts at establishing whether
eam rate in the treatment plan has an effect on the ﬂu-
nce map  conversion. In theory, a lower gamma  index value
ndicates an exact ﬂuence map  conversion and, accordingly,
 higher gamma index value demonstrates bigger differences
etween optimal and actual ﬂuence maps.otherapy 1 7 ( 2 0 1 2 ) 97–103 99
3.4. Comparison  between  calculated  actual  ﬂuence
maps  and  measured  actual  ﬂuence  maps
Additionally, for every treatment plan calculated for both
beam rates, the veriﬁcation plan was prepared, using the Por-
tal Dosimetry option of Eclipse TPS. Veriﬁcation plans contain
predicted actual ﬂuence maps, which are dose matrix, cal-
culated in a given Source-Detector Distance. Fluence maps
were measured by aS1000 EPID for both beam rates and
registered.8–13 All measurements were performed on one
accelerator with one MLC. For gamma index calculation, 3%
dose difference and 2 mm DTA were used. The calculated ﬂu-
ence map  was used as reference. It is believed that gamma
evaluation method is able to provide information about the
quality of irradiation. Its value corresponds to the quality of
treatment delivery.
Gamma  index was calculated in the surface area equal
to the rectangular treatment ﬁeld extended by 1 cm around
treatment ﬁeld sizes. This area covers part of portal detec-
tors covering the treatment ﬁeld, so it shows how the dose is
deposited within the treatment ﬁeld. In the study, the gamma
index calculated in a limited area is denoted by GI+1. In this
part of the study, different nomenclature for gamma index was
used to make a clear distinction between this calculation and
the one in Section 3.3.
3.5.  Comparison  of  leaf  motion
MLCtracker is a self-made software, deriving leaf motion
details from DynaLog ﬁles containing, among other data, MLC
details.14–16 It allows to read out leaf position every 50 ms  and
to analyze inaccuracy in MLC motion for bank A and B, sep-
arately. Predictable pattern of leaf position, changeable over
time, is compared with the actual one. For calculation of total
leaf movement  deviation, the root mean square is used. The
error values of leaf positions are a function of the number of
leaves. Then, MLCtracker calculates relative surface under the
curved line. Ultimately, an aggregate value is calculated for
both banks and marked as a relative integral. The value of the
relative integral represents inaccuracy in every motion of a
pair of leaves. The work of all pairs of leaves is analyzed, even
leaves outside treatment ﬁeld are considered. In this study,
the software serves for analysis of leaves’ precision for both
beam rates. Utilization of different beam rates in treatment
ﬁelds can be an important factor in discussion of accuracy in
treatment delivery.
4.  Results
4.1.  Comparison  of  dose  distribution
Analysis of RPI indicates that there is no signiﬁcant dif-
ference between its values calculated for 100 MU/min and
600 MU/min, separately. Although 100 MU/min plans are char-
acterized by higher RPI values for every patient. The average
value for 100 MU/min is 0.525 while for 600 MU/min  it is 0.522.
Average RPI values calculated for every patient separately are
shown in Fig. 1.
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Fig. 1 – Comparison of average RPI value calculated for
plans with 100 MU/min and 600 MU/min beam rate. For
most cases average RPI value is higher in 100 MU/min than
in 600 MU/min plans, what  means better dose distribution
in plans with lower beam rate.
Fig. 3 – Optimal ﬂuence maps vs. actual ﬂuence maps.
Comparison of gamma  index calculated for plans with
100 MU/min and 600 MU/min beam rate. Lower gamma
index value indicates better congruity of optimal and actual
ﬂuence maps. For all cases lower gamma  index for
100 MU/min was achieved.
Fig. 5.4.2.  Comparison  of  MUs
In both types of plans total number of MUs  differed clearly. For
100 MU/min plans, the average total MU  number is 594 while
for 600 MU/min the average total number of MU is higher and
equals 740. Numbers of MUs  calculated for both beam rates
and for all patients are presented in Fig. 2.
4.3. Comparison  between  optimal  and  actual  ﬂuence
maps
The comparison between optimal and actual ﬂuence maps
shows that the gamma index values are lower for 100 MU/min
than for 600 MU/min. The minimum gamma value is lower for
100 MU/min (0.28 vs. 0.31) and the same trend is visible for the
maximum value (0.59 vs. 0.67), the average value (0.43 vs. 0.48)
and the median value (0.42 vs. 0.47). Standard deviations are
respectively: 0.08 and 0.09. Thus, average gamma calculated
to assess accuracy of ﬂuence map  conversion indicates bet-
ter results for lower beam rate. Gamma  indices calculated for
every patient are shown in Fig. 3.Fig. 2 – Comparison of number of monitor units (MUs)
calculated in 100 MU/min and 600 MU/min plans. For all
cases lower MU  number is achieved in 100 MU/min plans
than in 600 MU/min plans.4.4.  Comparison  between  calculated  actual  ﬂuence
maps  and  measured  actual  ﬂuence  maps
Differences between the predicted actual maps and the mea-
sured actual maps were evaluated with the gamma index.
The GI+1 parameter calculated for two beam rates shows bet-
ter results for 100 MU/min than for 600 MU/min. The gamma
index values calculated from all treatment ﬁelds in the
described area are as follows: minimum – 0.42 vs. 0.45, maxi-
mum – 0.57 vs. 0.65, median – 0.42 vs. 0.46, average – 0.42 vs.
0.45 and standard deviation – 0.06 vs. 0.07. Fig. 4 represents
comparison of GI+1 calculated for both beam rates.
4.5.  Comparison  of  leaf  motion
Accuracy of leaf motion was evaluated by comparing calcu-
lated and actually reached leaf positions. It was found that
there is a correlation between beam rate and leaf motion
accuracy. Better compatibility of calculated and actual leaf
positions was represented in all plans with 100 MU/min beam
rate. Results achieved for both beam rates are presented inFig. 4 – Calculated vs. measured actual ﬂuence maps.
Comparison of gamma  index (GI+1) calculated for
100 MU/min and 600 MU/min in area limited to treatment
ﬁeld plus 1 cm.  Lower gamma  index value indicates better
congruity of calculated and measured actual ﬂuence maps.
For all cases lower value of GI+1 for 100 MU/min was
obtained.
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Fig. 5 – Comparison of summary leaves position inaccuracy
detected for 100 MU/min and 600 MU/min beam rates.
Leaves position error is expressed by sum of integrals
calculated for root mean square curve and named relative
integral. For all cases bigger error occurs in 600 MU/min
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Fig. 7 – Changes of total number of monitor units (MUs) perlans.
.  Discussion
imilar dynamic IMRT  plans can be obtained with different
eam rates, correlating with given dose rates. Different accel-
rator modes thus help deliver dose with different beam rates
n a shorter or longer time. However, analysis of several values
et us observe some differences in treatment plans. Generally,
avorable dose distribution, assessed with RPI, was found in
lans with a lower beam rate (0.525 vs. 0.522 in Fig. 6). But it
annot be claimed that the usage of a higher beam rate leads
o unacceptable dose distribution. Differences between dose
istributions are subtle, but are in favor of lower beam rates
or all analyzed cases (p = 0.0033, Wilcoxon Test).
When analyzing the total treatment time expressed by the
umber of MUs, it was shown that average number of MUs  per
raction is lower for 100 MU/min beam rate (594 MU)  than for
00 MU/min (740 MU) (p = 0.0022, Wilcoxon Test). The compari-
on is shown in Fig. 7. The minimum and maximum numbers
f MUs  for the 100 MU/min plans were respectively 26% and
6%, and were lower than for the 600 MU/min plans. Similarly,
he average and median numbers of MUs  were respectively
0% and 21% and were lower for 100 MU/min plans. Another
ig. 6 – Changes of average Radiation Planning Index (RPI)
ith the beam rate.treatment plan with the beam rate.
study has also examined the effect of altering dose rates from
100 MU/min to 600 MU/min on the number of monitor units.17
The results demonstrated the same tendency, i.e. the higher
the dose rate the higher the number of MUs.
However, treatment time expressed in minutes equaled
about 1.2 min  for 600 MU/min and was shorter than treatment
time for 100 MU/min, which equaled almost 6 min  per fraction.
Our conclusions coincide with those of the above mentioned
study.17 This aspect should be considered for the sake of treat-
ment accuracy. Longer treatment time can cause signiﬁcant
patient mobility and thus worsen irradiation precision.17 Pos-
sible patient motions implicate dose delivery problems. This
may result in unintended tumor underdosage or overdosage in
organ at risk volumes. Frequent patient imaging during treat-
ment would reduce such problems.18–21 But common imaging
procedures for patient setup are carried out before beam on.
In practice, intrafraction patient repositioning is very rarely
performed. This may not be sufﬁcient to ensure an accurate
treatment. Therefore, it should also be discussed if favorable
dose distribution in the treatment plan (obtained with longer
treatment time calculated in TPS) outweighs the gains of a
shorter overall treatment session. On the other hand, exten-
sive and long-term procedures would also result in longer total
treatment time. On line correction prolongs the irradiation
procedure.18,19 As well known, longer treatment delivery can
cause more  frequent patient motions and higher probability
of complications.
With regard to gamma indices calculated in the OmniPro-
I’mRT software for comparison of optimal and actual ﬂuence
maps, it was shown that beam rate inﬂuences conversion
accuracy. The converted ﬂuence maps were in a better agree-
ment with calculated ones for 100 MU/min (mean gamma
index value equals 0.43) than for 600 MU/min beam rate (mean
gamma index value equals 0.48). The results were statistically
signiﬁcant (p < 0.05, Wilcoxon Test).
Therefore, another question arises of whether conver-
sion accuracy is correlated with treatment accuracy. In
this study, treatment accuracy was analyzed in two ways:
ﬁrstly, leaf motion precision was evaluated in ﬂuence maps
102  reports of practical oncology and radiotherapy 1 7 ( 2 0 1 2 ) 97–103
Fig. 8 – Dependence between inaccuracy of map  conversion
represented by gamma  index calculated in OmniPro-I’mRT
software and treatment execution represented by GI+1
calculated in Portal Dosimetry option for (A) 100 MU/min
and (B) 600 MU/min beam rates. The dashed line indicates
95% conﬁdence range (Statistica v.8).
Fig. 9 – Dependence between inaccuracy of map  conversion
represented by gamma  index calculated in OmniPro-I’mRT
software and treatment execution represented by leaves
motion precision, calculated in MLCtracker software for (A)
100 MU/min and (B) 600 MU/min beam rates. The dashed
line indicates 95% conﬁdence range (Statistica v.8).
tion has to be provided that the correlation is not shownmeasurement assessing gamma  index GI+1 and secondly,
with MLCtracker software. Then, the correlation of conver-
sion accuracy with GI+1 and, additionally, with leaves’ motion
precision was examined.
There was a small correlation between the conversion qual-
ity and treatment delivery made on the basis of GI+1 for
both beam rates. GI+1 represented agreement between calcu-
lated and measured maps, that is ﬂuence map  execution. An
increase in inaccuracy of map  conversion caused the increase
in inaccuracy of ﬂuence map  execution, i.e. gamma index
values calculated for both comparisons varied in direct pro-
portion. The relationship is presented in Fig. 8. Single points
on the graph show values calculated for every treatment ﬁeld,
separately. This dependence is slightly bigger for 600 MU/min
than for 100 MU/min. Consequently, lower treatment precision
for higher beam rate can be expected. The correlation factor
is low but the result is statistically signiﬁcant (p < 0.005).
The impact of different dose rates on actual ﬂuence maps
was tested by Vorwerk et al. as well.17 The results indicated
that gamma index was correlated with the dose rate. The
mean gamma index was lower using a dose rate of 100 MU/min
than 600 MU/min.Another test could also demonstrate how the differences in
optimal and actual maps corresponded to the leaf positioning
precision. The conclusion can be drawn that there is no cor-
relation between the deviation of optimal and actual ﬂuence
maps found in the planning phase and the inaccuracy during a
treatment session. Again the result is statistically signiﬁcant.
The relationship between leaf motion precision and ﬂuence
map  conversion accuracy is presented in Fig. 9.
It is notable that changes in ﬂuence map  delivery can be
caused not only by improper leaf motion but also by beam
rate changes. These changes are unintentional, but do occur
in the IMRT modality. Obviously, such discrepancy can make a
considerable contribution to ﬂuence map  variances. If so, we
have to make sure what exactly we  are testing. The MLCtracker
controls MLC  ﬁles only, while the GI+1 considers leaf motion
as well as possible dose rate ﬂuctuations. Perhaps, for this
reason correlation between ﬂuence map  conversion accuracy
and ﬂuence map  delivery was demonstrated, whereas such
correlation for leaf motion precision was not proven.
To obtain a complete view of this problem, an explana-because the position of the leaves is averaged from thousands
of numbers during a relative integral calculation. Therefore,
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solated local leaf position distortions can go unreported, as
verage values do not fully illustrate whole movement  fea-
ures. But such a small imprecision in leaf movement  can be
llustrated on a ﬂuence map  and measured by GI+1. However,
he leaf motion inaccuracy clearly depends on beam rate. It
ises as beam rate increases. It is coherent with the result
f another study of Stell et al.22 It should be also empha-
ized that detected discrepancies occurring in the course of
reatment do not exceed tolerance values deﬁned in limits
or leaf parameters.23 Otherwise, treatment delivery would be
nterrupted. Further investigation of MLCtracker outcomes is
lanned by the authors. However, it can be stated that this
oftware has a practical application in daily quality assurance
arried out for dynamic techniques. Its implementation allows
o read out of leaf motion accuracy and compare it with the
alculated one.
.  Conclusion
eam rate analysis can help yield new insights into the dis-
ussion on treatment planning and treatment delivery quality
ssurance (QA). Applying different beam rates, one can obtain
ifferent levels of dose distribution and treatment precision.
owever, these differences are minor. The only parameter
eﬂecting the beneﬁts of a higher beam rate is treatment time,
.e. treatment session duration. The rest of the analyzed fac-
ors show superiority of a lower beam rate, which, however,
oes not have a signiﬁcant impact on differences in treatment
ccuracy. In the future, the impact of intrafraction movements
f the patient, caused by long treatment duration, on treat-
ent precision can be considered.
Lastly, it should be mentioned that the above discussion
oncerns physical doses only. Possible inﬂuence of beam rate
n biological effects remains to be an open issue.
onﬂict  of  interest
one declared.
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